HCLTech has partnered with Microsoft by joining the Microsoft Discovery Platform, aiming to accelerate breakthroughs in scientific research. The collaboration will focus on chemistry, materials science, drug discovery, and semiconductor design, leveraging AI-driven tools to enhance R&D workflows and scale enterprise innovation across multiple industries.
HCLTech has officially joined the Microsoft Discovery Platform, marking a strategic collaboration designed to fast-track innovation in scientific research and development. The partnership brings together HCLTech’s deep domain expertise and Microsoft’s advanced AI infrastructure to support transformative projects in areas such as drug discovery, materials science, and semiconductor design.
Key highlights from the announcement include
-
HCLTech will participate in technical onboarding and collaborative R&D projects under the Microsoft Discovery Platform.
-
The initiative targets breakthroughs in chemistry, materials science, drug development, and semiconductor innovation.
-
AI-powered tools will be used to automate workflows and enhance experimental simulations.
-
The platform enables integration of enterprise-scale applications with Microsoft’s extensible AI ecosystem.
-
HCLTech aims to empower global R&D teams with scalable, intelligent solutions.
-
The collaboration supports faster hypothesis formulation, iterative learning, and advanced knowledge reasoning.
-
This move aligns with HCLTech’s broader strategy to lead in digital transformation and responsible AI adoption.
By joining the Microsoft Discovery Platform, HCLTech reinforces its commitment to driving scientific progress through technology, positioning itself as a key player in the future of enterprise-led research innovation.
Sources: InvestyWise, HCLTech Official Website, Microsoft Azure Blog